FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Mankind Pharma IPO.
May 3, 2023 7:02:00 PM
Mankind Pharma is likely to announce its share allotment status on May 3. The IPO received great demand from investors as the issue was subscribed 15.32 times. The shares will be listed on May 8 ...
Published by : Business Insider IndiaJuly 10, 2024 7:00:00 AM
CNBC-TV18 had reported on Tuesday that Capital Group Affiliate, Hema CIPEF plans to sell 0.9% of the company's equity via block deals valued at nearly ?762.6 crore.
Published by : cnbctv18November 9, 2023 1:05:00 PM
The IPO received significant attention, with a subscription rate of 106.06 times. Mankind Pharma shares concluded their listing day with a substantial premium of 32% on NSE at Rs 1397.6. Currently ...
Published by : Business TodayApril 3, 2024 10:52:00 PM
and upto 50,000 shares by Link Investment Trust Tek TBO IPO: Here's what a host of brokerage firms say about the issue Indegene IPO: All details you need know including price band, key dates ...
Published by : Business TodayJuly 1, 2024 4:59:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range ... of 33.86), Torrent Pharmaceutical Ltd (with a P/E of 57.74), Mankind Pharma (with a P/E of 45.30), Abbott India Ltd (with ...
Published by : MintJuly 10, 2024 9:13:00 AM
Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9% in debut trade on Wednesday, beating analysts' estimates and valuing the company at 18.64 billion rupees ($223.3 million), as its strong ...
Published by : ReutersJuly 4, 2024 2:44:00 PM
Also Read: Emcure Pharmaceuticals IPO day 2: GMP, subscription status ... Torrent Pharmaceutical Ltd (P/E: 57.74), Mankind Pharma (P/E: 45.30), Abbott India Ltd (P/E: 47.43), J.
Published by : MSNJuly 5, 2024 3:30:00 AM
The Bain Capital-backed company's IPO was fully subscribed on the first day of bidding ... The generics market is dominated by firms such as Sun Pharma, Mankind Pharma, Torrent Pharma and Abbott India ...
Published by : VCCircleJuly 3, 2024 4:12:00 AM
Emcure Pharmaceuticals IPO, which is set to start with a share ... (RHP), are Torrent Pharmaceutical Ltd (P/E of 57.74), Mankind Pharma (P/E of 45.30), Abbott India Ltd (P/E of 47.43), J.
Published by : MSNJune 28, 2024 6:47:00 PM
The IPO comprises a fresh issue of ?800 Crore ... Alkem Laboratories, Torrent Pharmaceuticals, Mankind Pharma, Abbott India, and JB Chemicals. The company will debut on the BSE and NSE on ...
Published by : India InfolineJune 21, 2024 10:38:00 PM
Use of IPO Proceeds Emcure Pharmaceuticals plans ... Alkem Labs, Torrent Pharma, Mankind Pharma, and Abbott India.
Published by : India InfolineThe IPO Shares of Mankind Pharma Limited IPO are proposed to list on Tuesday, May 9, 2023 at BSE, NSE. The public issue of Mankind Pharma IPO was opened on Apr 25, 2023 and closed for subscription on Apr 27, 2023. Mankind Pharma IPO Listing Date and Information:
Listing Date | Tuesday, May 9, 2023 |
BSE Script Code | 543904 |
NSE Symbol | MANKIND |
Listing In | B Group of Securities |
ISIN | INE634S01028 |
Issue Price | [.] |
Face Value | ₹1 Per Equity Share |
The allotment status of Mankind Pharma Limited IPO is now available online. The public issue of Mankind Pharma IPO was open on Apr 25, 2023 and closed for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE
.
Mankind Pharma Limited is entering in the capital market with an IPO of 40,058,844 Equity Shares of Rs 1 aggregating up to Rs 4,326.36 Crore. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.
Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.
The issue opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE.
The issue of Mankind Pharma Limited opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.
The Mankind Pharma IPO is proposed to open on April 25, 2023. The IPO application ends on April 27, 2023.
Retail investors can apply in the retail or non-institutional investor category from April 25, 2023 to April 27, 2023. The Mankind Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Mankind Pharma IPO will open for subscription on April 25, 2023. The public issue will close on April 27, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|